在受污染的环境中吸入过敏的诊断和治疗
Marcel Mazur1, Ewa Czarnobilska1
1Department of Clinical and Environmental Allergology, Medical College, Jagiellonian University, Botaniczna St. 3, 31-501 Krakow, Poland.
International journal of molecular sciences
|July 12, 2025
概括
空气污染加剧了过敏性鼻炎 (AR) 和喘等过敏性疾病. 它可能会降低过敏原免疫疗法 (AIT) 的有效性,使诊断和治疗复杂化,需要精确医学方法.
科学领域:
- 环境科学 环境科学
- 过敏学 过敏学
- 免疫学 免疫学 免疫学
背景情况:
- 在全球范围内,过敏性疾病正在增加.
- 空气污染和气候变化加剧过敏状况,包括过敏性鼻炎 (AR) 和喘.
- 污染会改变花粉的特性,增加过敏性,并使诊断和治疗复杂化.
研究的目的:
- 调查空气污染对过敏疾病,特别是AR的诊断和治疗的影响.
- 评估过敏原免疫疗法 (AIT) 在污染环境中的有效性.
- 探索分子诊断在污染环境中的过敏管理中的作用.
主要方法:
- 对空气污染,气候变化和过敏性疾病的现有研究进行审查.
- 分析在污染环境中诊断和治疗AR的挑战.
- 讨论对过敏原免疫疗法 (AIT) 和分子诊断的影响.
主要成果:
- 空气污染加剧AR和喘,并可以揭露无症状过敏.
- 标准的过敏治疗和AIT可能在受污染的环境中效果较差.
- 分子诊断非常重要,但它们在污染环境中的有效性需要进一步评估.
结论:
- 环境因素显著影响过敏疾病的流行和管理.
- 精准医学和环境管理是解决日益增加的过敏疾病负担的关键.
- 需要进一步的研究来优化AIT和对暴露于空气污染的患者的诊断方法.
相关概念视频
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Allergic Reactions
28.8K
Overview
28.8K
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
471
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
471
Inhaled Medications
396
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
396
Asthma: Pathogenesis and Management
606
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
606


